FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 10

Author

Admin 422 posts 0 comments

Featured News

The Growing Adoption of Digital Payments and the Cashless Economy Revolution

Admin Nov 26, 2025
The financial sector is undergoing a transformative shift as consumers and businesses increasingly prefer digital…
Featured News

India’s Premium Housing Market Drives Value Despite Slower Volume

Admin Nov 25, 2025
India’s real estate landscape is witnessing a notable shift in 2025: even though the total number of homes sold is…
Featured News

Fintech-Driven Real Estate Platforms Gain Momentum as Digital Financing Transforms…

Admin Nov 24, 2025
A new market intelligence report released this week shows a dramatic rise in fintech-powered real estate…
Whitepaper

Driven by dollars: The role of compensation in life insurance agent placement…

Admin Nov 21, 2025
Compensation drives placement decisions in ways most don’t recognize. Case in point: 62% of agents actively prefer…
Featured News

Finance and Banking Fraud: The Silent Threat Undermining Global Trust

Admin Nov 20, 2025
Financial institutions worldwide are facing a wave of sophisticated fraud schemes driven by digital acceleration,…
Featured News

What’s Real and What’s Hype in 2026 Insurance

Admin Nov 19, 2025
Go beyond the buzzwords. This report cuts through the hype to reveal the real shifts in AI, climate risk, embedded…
Featured News

Global Economic Fragmentation and Persistent Inflation Challenges

Admin Nov 18, 2025
The global financial landscape in 2025 is increasingly defined by economic fragmentation and the persistent…
Articles

The Convergence of Fintech and Martech Is Redefining Customer Experience

Admin Nov 17, 2025
The boundary between fintech and martech is rapidly dissolving as companies push for personalized, automated, and…
Featured News

Indian Fintech Funding Plunges 48 % in Q3 2025 as Investors Turn Cautious

Admin Nov 14, 2025
In India’s fintech sector, funding in Q3 2025 fell sharply by 48% quarter-on-quarter, with the average deal size…
Articles

Disrupting Finance and Rewriting the Rules of Competition

Admin Nov 13, 2025
Financial technology (“fintech”) has moved well beyond being a buzzword. It is rewriting how financial services…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human...


    SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
    2026-05-13T20:05:00Z
    Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue


    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    2026-05-13T20:05:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach...


    Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026


    Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
    2026-05-13T20:05:00Z
    JUPITER, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...


    Bionano Reports First Quarter 2026 Results and Provides a Business Update
    2026-05-13T20:05:00Z
    Conference call today, May 13, 2026, at 4:30 PM ET


    LogicMark, Inc. Announces Strong First Quarter 2026 Results
    2026-05-13T20:05:00Z
    Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows


    IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
    2026-05-13T20:05:00Z
    NASHVILLE, Tenn., May 13, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its first quarter results:


    Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:05:00Z
    100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study


    Glass House Brands Reports First Quarter 2026 Financial Results
    2026-05-13T20:05:00Z
    LONG BEACH, Calif. and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF),...


    Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
    2026-05-13T20:05:00Z
    REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial...


    Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with...


    Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    MIAMI, May 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial...


    Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T20:03:27Z
    ORKA-001 EVERLAST-A 16-week data showed 63.5% PASI 100 rate and a favorable tolerability profile, with longer-term data expected in 2H 2026


    Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
    2026-05-13T20:02:00Z
    SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for...


    vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T20:01:00Z
    Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026


    Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
    2026-05-13T20:01:00Z
    Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected approximately six months thereafter


    Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-05-13T20:01:00Z
    Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million


    aTyr Pharma to Participate in Upcoming Investor Conferences
    2026-05-13T20:01:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary...


    MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
    2026-05-13T20:01:00Z
    ROCKVILLE, Md., May 13, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today reported financial...


    Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:01:00Z
    WARREN, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through...


    Medicenna Announces the Launch of a Marketed Public Offering of Securities
    2026-05-13T20:01:00Z
    NOT FOR DISSEMINATION INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES


    Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
    2026-05-13T20:00:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting...


    Mdxhealth Reports Q1-2026 Results
    2026-05-13T20:00:00Z
    Mdxhealth Reports Q1-2026 Results


    Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
    2026-05-13T19:01:16Z
    COPENHAGEN, Denmark, May 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or...


    MAPS Announces Dates for Psychedelic Science 2027; Early Bird Registrations Now Open
    2026-05-13T18:47:53Z
    DENVER, May 13, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced that early bird registrations are now open for Psychedelic Science 2027 (PS27), taking place May...


    Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations
    2026-05-13T18:09:42Z
    Investigational New Drug application for KHN921 received “study may proceed” from the US FDA. KHN921 is a potential "first-in-class" cardiovascular AAV gene therapy being developed for the treatment of hypertrophic...


    AB Science reports its revenues for the year 2025 and provides an update on its activities
    2026-05-13T17:36:48Z
    PRESS RELEASE


    JavaTide Claims Evaluated: Investigating the Java Tide Ingredients for Purity and Potency
    2026-05-13T17:01:03Z
    JavaTide Prebiotic and Probiotic Weight Loss Support: Chicory Root Inulin, Resistant Starch, and Akkermansia muciniphila for Gut Health and Metabolism Explained


    Ipsen S.A. – Evolution of the composition of the Board of Directors
    2026-05-13T16:15:00Z
    Ipsen S.A. – Evolution of the composition of the Board of Directors

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.